What are the treatment options for an 86-year-old man with benign prostatic hyperplasia status post transurethral resection of the prostate who has recurrent urinary tract infections and a recent urine culture growing Pseudomonas?

Treatment Approach for Recurrent UTIs with Pseudomonas in an 86-Year-Old Post-TURP Patient

For this 86-year-old man with recurrent UTIs and Pseudomonas after TURP, treat the acute infection with culture-directed antibiotics (typically a fluoroquinolone or anti-pseudomonal beta-lactam based on susceptibilities), then implement long-term antimicrobial prophylaxis if non-antimicrobial preventive measures fail, while evaluating for residual anatomic obstruction or incomplete bladder emptying that may require urological re-intervention.

Acute Infection Management

Immediate Treatment

• Obtain urine culture with antimicrobial susceptibility testing before initiating therapy 1
• For Pseudomonas specifically, empirical choices include:
  • Ciprofloxacin 400 mg IV twice daily or 500-750 mg PO twice daily 1
  • Levofloxacin 750 mg daily 1
  • Ceftazidime, cefepime, or piperacillin/tazobactam for resistant strains 1
  • Newer agents (ceftolozane/tazobactam, ceftazidime/avibactam, cefiderocol) if multidrug-resistant 1

Treatment Duration

• 7-14 days is reasonable for complicated UTI in this setting 2
• Adjust based on clinical response and culture results
• Given his age and post-TURP status, this represents a complicated UTI requiring longer treatment than simple cystitis 1

Critical Diagnostic Evaluation

Identify Underlying Causes

Post-TURP patients with recurrent UTIs require assessment for:

• Post-void residual urine volume - elevated residuals indicate incomplete bladder emptying 3
• Upper urinary tract imaging (ultrasound initially) to rule out hydronephrosis or stones 1
• Bladder outlet obstruction - may indicate inadequate initial TURP or recurrent obstruction 3
• Detrusor underactivity - common in elderly men and can cause retention 4

Important caveat: Recurrent UTI after TURP is actually an indication for surgical re-evaluation 5, 3. The initial TURP may have been incomplete, or there may be other anatomic issues.

Long-Term Prevention Strategy

Non-Antimicrobial Measures (First-Line)

The 2024 EAU guidelines provide a hierarchical approach 1:

• Increase fluid intake (weak recommendation but reasonable)
• Methenamine hippurate - strong recommendation for preventing recurrent UTIs in patients without urinary tract abnormalities 1
• Immunoactive prophylaxis - strong recommendation for all age groups 1
• Probiotics - weak evidence but may consider 1
• Cranberry products or D-mannose - weak and contradictory evidence 1

Antimicrobial Prophylaxis (When Non-Antimicrobial Fails)

• Use continuous antimicrobial prophylaxis only after non-antimicrobial interventions have failed 1
• For chronic bacterial prostatitis (which may be contributing), consider 6-12 weeks of fluoroquinolone therapy 6
• Long-term suppressive therapy may be necessary in selected patients with persistent recurrences 6

Critical consideration: At age 86, this patient likely has multiple risk factors including:

• Advanced age (≥85 years associated with higher complications) 7
• Possible detrusor underactivity 4
• Potential incomplete bladder emptying 3

Special Considerations for Pseudomonas

Why Pseudomonas Matters

• Pseudomonas is significantly enriched in BPH tissues and may promote prostatic inflammation through NF-κB signaling 8
• This organism shows high resistance rates to commonly used antibiotics in elderly BPH patients 9
• Resistance patterns from a 2021 study showed Pseudomonas aeruginosa comprised 5.7% of isolates in elderly BPH patients 9

Antibiotic Selection Pitfalls

Avoid empirical use of:

• Trimethoprim-sulfamethoxazole (>50% resistance in elderly BPH patients) 9
• Ciprofloxacin (>50% resistance) 9
• Cephalosporins (variable resistance) 9

Better empirical choices (pending susceptibilities):

• Amikacin (1% resistance) 9
• Piperacillin/tazobactam (13% resistance) 9
• Carbapenems (minimal resistance) 9

Urological Re-Evaluation

When to Consider Repeat Intervention

Given that recurrent UTI is an indication for surgical treatment in BPH patients 3, this patient needs:

• Cystoscopy to evaluate for:
  • Residual prostatic tissue
  • Bladder stones (a complication of BPH requiring surgery) 5
  • Urethral stricture
• Urodynamic studies if detrusor underactivity suspected 4

Surgical Success Considerations

For extremely elderly patients (≥85 years), TURP outcomes show 7:

• 84% catheter-free at 3 months
• 30% complication rate at 30 days
• Risk factors for failure: age ≥90, WHO performance status ≥3, post-void residual >1500 mL

Practical Algorithm

1. Treat acute infection with culture-directed therapy (7-14 days)
2. Measure post-void residual and obtain renal ultrasound
3. If elevated residual or hydronephrosis → urology referral for possible repeat TURP
4. If normal anatomy → initiate non-antimicrobial prophylaxis (methenamine hippurate + immunoactive prophylaxis)
5. If recurrences continue → consider continuous antimicrobial prophylaxis with agent based on prior susceptibilities
6. Monitor for bacteremia risk - 9% of elderly BPH patients with UTI develop bacteremia 9

The key insight is that this patient's recurrent UTIs likely represent treatment failure of the initial TURP rather than simply recurrent infection, requiring both infectious disease management and urological re-evaluation 5, 3.